Wednesday, March 29, 2023
News
NEWS HOME
PRN INDIA
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study
  SocialTwist Tell-a-Friend  
   

GENEVA, Jan. 26, 2023 /PRNewswire/ -- The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US in October 2022. SELUTION SLR is the first sustained limus release coronary drug-eluting balloon (DEB) to receive FDA IDE approval for In-stent restenosis (ISR) indications.

MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study

"We are very excited to have enrolled our first US patient," commented Dr Don Cutlip, Co-Principal Investigator of the IDE SELUTION4ISR Study and the Chief Medical Officer at Baim Institute for Clinical Research. "This study addresses the important unmet need of treatment for the ongoing problem of in-stent restenosis without adding an additional layer of metal stent."

"This is an exciting day for PCI in the USA. DEB is the standard of care for ISR around the world, with the exception of the US. Treating coronary ISR is challenging and having DEB technology made available through a well-designed and conducted randomized clinical trials is the next step. This trial is now underway and this is great for our patients!" added Co-Principal Investigator Prof. Roxana Mehran, Mount Sinai Professor in Cardiovascular Clinical Research and Clinical Trials.

"This is another significant milestone for MedAlliance: we were the first sustained limus release balloon to receive FDA IDE approval, the first to treat a US peripheral patient and now the first to treat a US coronary patient. This is the culmination of a multi-year R&D program that delivered comprehensive pre-clinical data meeting the very high standards of the US FDA," added Jeffrey B. Jump, MedAlliance Chairman and CEO. "We are very pleased with the high level of market acceptance we are experiencing in Europe, Asia and South America, and we look forward to entering the US market following FDA approval."

Enrollment of the IDE SELUTION4ISR FDA coronary study is ongoing outside the US and additional US centers will soon join MedStar Washington Hospital Center after this first US enrollment. (ClinicalTrials.gov Identifier: NCT04280029).

MedAlliance received on Jan 6th IDE approval for coronary de novo indications. The OUS SELUTION DeNovo study has more than 800 patients of the 3,326 enrolled in this ground-breaking coronary randomized study comparing treatment strategy with SELUTION SLR (DEB) vs. Limus drug eluting stent (DES) strategy.

SELUTION SLR was awarded CE Mark Approval for the treatment of coronary artery disease in May 2020. MedAlliance was the first drug-eluting balloon company to receive FDA Breakthrough Designation status. In addition to the BTK and superficial femoral artery (SFA) indications for which the company received FDA IDE approval in May and August 2022, MedAlliance received coronary in-stent restenosis (ISR) IDE approval in October 2022 and de novo coronary artery lesions on January 6th 2023, which will complement the substantial experience that the company has gained with the SELUTION DeNovo trial in Europe.

MedAlliance's unique DEB technology involves MicroReservoirs which contain a mixture of biodegradable polymer intermixed with the anti-restenotic drug 'sirolimus' applied as a coating on the surface of an angioplasty balloon. These MicroReservoirs provide controlled and sustained release of the drug for up to 90 days. MedAlliance's proprietary CAT™ (Cell Adherent Technology) enables the MicroReservoirs to be coated onto balloons and efficiently transferred to adhere to the vessel lumen when delivered via expansion of the balloon.

SELUTION SLR is commercially available in Europe, Asia, the Middle East, and the Americas (outside USA) and most other countries where the CE Mark is recognized. Over 10,000 units have been used for patient treatments in routine clinical practice or as part of coronary clinical trials. Centres interested in participating in this study, please contact MedAlliance.

About MedAlliance

MedAlliance is medical technology company which announced a staged acquisition by Cordis in October 2022. It is headquartered in Nyon, Switzerland, MedAlliance specializes in the development of ground-breaking technology and commercialization of advanced drug device combination products for the treatment of coronary and peripheral artery disease. For further information visit: www.medalliance.com

Media Contact:

Richard Kenyon
rkenyon@medalliance.com
+44 7831 569940

Photo: https://mma.prnewswire.com/media/1989732/MedAlliance_Image.jpg
Logo: https://mma.prnewswire.com/media/1196864/MedAlliance_Logo.jpg

MedAlliance Logo

Cision View original content:https://www.prnewswire.com/in/news-releases/medalliance-leads-us-sirolimus-deb-race-first-us-patient-enrolled-into-selution-slr-coronary-sirolimus-deb-study-301730514.html

More News by PR Newswire India

Great Place To Work India and HDFC ERGO come together to drive the movement of 'Making India a Healthy Place to Work For All'

NetEase announces "Lord of the Rings" Game Fanfiction Contest

Shoolini Engineering Earns High SCImago Rankings

Advertising legend Raj Kamble is the only Indian Nominee at Campaign's Global Agency of the Year Awards 2023 list

MIT Technology Review Examines the Emergent Industrial Metaverse with Siemens AG

BRITISH VIRGIN ISLANDS COMPANIES SUPPORT 2.3M JOBS AND GENERATE US$14BN IN TAX REVENUES GLOBALLY

Teleperformance launches its futuristic new site in Hyderabad

A Resolution through Farmer's Training on the Water Crisis Management in Agrarian India

E Ink Teams up with Indian Tech OEM SuperUs to Drive Localization in India

Valuebound Attains AWS Advanced Consulting Partner Status, Offering Expert Cloud Migration Services

SafeHouse Tech launches SafetyScore to assess user's safety online

Mentoria Partners with Governments and Foundations to Make India #CareerReady

People in Asia seek to extend health span for longer, healthier retirement, Manulife survey shows

Omdia: Samsung leads while BOE increases small medium AMOLED shipment market share in 2022

BMO Recommends Shareholders Reject TRC Capital's Below-Market "Mini-Tender" Offer

APPTIO INDIA LLP Is Great Place to Work Certified for Second Year

BETT 2023: ViewSonic to Debut Expanded EdTech Solutions Across UNIVERSE Virtual Campus and myViewBoard Ecosystem

LE DU IN BANGKOK CLAIMS NO.1 SPOT AT ASIA'S 50 BEST RESTAURANTS 2023

MNCs View CIIE as Launch Pad into Chinese Market

Kivu Consulting, Inc. announces strategic partnership with Microsoft

Argentina's Minister of Economy Sergio Tomás Massa and Top Silicon Valley Investors Marc Andreessen and Ben Horowitz to Speak at PRIORITY, Powered by FII Institute

Kixx Aims to Become Top Lubricant Brand Around the World, Highlighting Its Advanced Industrial Lubricants

Movable Ink Launches New Mobile Suite to Help Brands Worldwide Better Engage Customers on Their Channel of Choice

BIMINI HEALTH TECH ACQUIRES EXCLUSIVE LICENSE TO ACELLULAR DERMAL MATRIX PRODUCT PORTFOLIO

VCTI Announces Appointment of Scott Widham to Board of Directors

Lacework Marries its Global Partner Ecosystem with the Cloud Security Needs of Customers

Sennheiser Profile USB microphone provides ease of use and best-in-class audio

IBM Brings Generative AI Commentary and Hole-by-Hole Player Predictions to the Masters Digital Experience

Kohler Presents 'The Creator's Journey' at Milan Design Week

Omega Seiki Mobility (OSM) partners with cKers Finance to provide retail finance for electric three wheelers

AV-Comparatives awarded best-performing IT security software at Hasegg Castle / Royal Mint in Hall, Tyrol

Colgate-Palmolive promotes 'Innovation in Oral Health' in association with Indian Dental Association

Allstate India Named One of India's 40 Best Workplaces in Health and Wellness 2022 by Great Place to Work® Institute

Yokogawa Releases OpreX Asset Health Insights with Enhanced Functionality and Alibaba Cloud Support

STL's optical products testing labs rated highest on stringent quality standards set by NABL and TEC

2023 Africa Wealth Report Reveals 'Big 5' Host 56% of Continent's Millionaires

Scharf Investments Global Equity Strategy Awarded Mandate from a Key Nordic Pension Fund

Medanta Gurugram recognized as the Best Private Hospital in India Fourth Time in a Row

Hexaware's Vikash Jain Honored at ASSOCHAM Vibrant Bharat CFO Summit & Awards and CFO100 2023 Programme for Outstanding Financial Leadership

VdoCipher Video Player Powers 3,000+ Platforms across 120+ Countries

UST's CSR Initiatives Recognised at 2023 KMA Awards

Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC

Colliers expands capital markets & investment business across asset classes

PR Newswire Sees 7% Growth in Asia-Pacific Release Distribution

QSnatch infections are the leading cause of malicious DNS traffic in Asia Pacific, according to latest findings by Akamai

KPG Roofings Opens Its First roof tile Showroom in Hyderabad and 40th showroom in India

Otr Elkalam: In the world's largest religious competition - A Saudi Opera Singer Eliminates a Voice Coach

The Organizing Committee of Memorial Ceremony to Ancestor Huang Di in his Native Place Held its Press Conference in Beijing

Aramco to expand presence in China by acquiring 10% stake in Rongsheng Petrochemical

BNI® TO HELP ITS MEMBERS DOUBLE VALUE OF THEIR BUSINESS

Syndigo Announces Additional Generative AI Capabilities to its Client Platform

2026 All-Time High in Store for Global 300mm Semiconductor Fab Capacity After 2023 Slowdown, SEMI Reports

Tata Communications brings JAMVEE™ - an integrated, simplified cloud-based calling solution for global enterprises

38th Annual World Petrochemical Conference: Wanhua Chemical Shares Inspiring and Insightful Practice on Sustainability in Petrochemical Industry

CONNECTING BUYERS, SELLERS TO $1 TRILLION M&A MARKET WITH NEW DEAL DISCOVERY SaaS SOLUTION

Shipping industry can save $50 bn through four enablers of operational efficiency

LyondellBasell and EEW sign LOI for potential advanced waste sorting

Armis Achieves U.S. Department of Defense Impact Level 4 Authorization

The Second International Forum on "Democracy: The Shared Human Values" kicked off in Beijing

Bitget Becomes the First Centralized Exchange to Offer Financial Transparency Through Space and Time

Forever New Launches Exquisite SS23 Collection Featuring Pooja Hegde

Transparent & good governance, inclusive Growth and opportunities for all mark the emergence of New India under the leadership of PM Narendra Modi says Union MoS Rajeev Chandrasekhar

Inkspell set to organize the Video Media (vIdea) Awards & Summit 2023 on 27th April

Indian Low-voltage Switchgear Market Witnesses Surge Due to Pent-up Demand and an Increase in the Average Price

Aramco JV HAPCO to commence construction of major refinery and petrochemical complex in China

GCL System Integration Brings N-Type Innovation TOPCon and Latest BIPV Products to PV EXPO 2023

Aditi Mittal, Director at IndiaBonds and A. K. Group wins Times 40 Under 40 Award

Beamery Announces TalentGPT, the World's First Generative AI for HR

Appian appoints Douglas Coleman as Head of Mexico

Measure the Impact of Mantras on the Brain with the Sadhana app

International Aluminium Institute launches Aluminium Forward 2030 Coalition

Bharat KYC secures 'Fastest eKYC' and QuantPower bags 'Best Algo Trading Platform' Award from NITI Ayog Advisor & Bollywood Diva Bhagyashree

Transcoding and Content Security Workflow Simplified: INKA Entworks's PallyCon and Dolby Hybrik Join Hands for an Integrated Solution

ESG practices towards transformative change for a more sustainable world

Making Open Source Truly Open

The 3rd Conference of Great Business Partners to be held in Shandong

New Cryptocurrency BASALTCOIN set to Launch with a Mission to Revolutionize the Greentech Industry

CGTN: How China keeps its promise to build a community of common health for mankind

CGTN: Analysis: China's economic resilience boosts global recovery prospects

YourStory's TechSparks makes thundering debut in Mumbai: A two-day gala featuring India's top entrepreneurs, investors, innovators, and more

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Electricity Amendment Bill not to impact...
Rajasthan govt ready to listen to doctor...
50 case files missing from Muzaffarnagar...
MBBS student jumps off autorickshaw as d...
Namibian cheetah's death at Kuno raises ...
Apologise or face Rs 100 cr defamation c...
More...    
 
 Top Stories
Gangster-turned politician Atiq Ahm... 
"Technological Innovation"- Last re... 
TechDost launches 'Vedmarg - Studen... 
Chitrangda Singh turns showstopper ... 
Rajya Sabha adjourned to meet again... 
MP CM Chouhan inaugurates Army Fair... 
India reports 2151 new COVID-19 cas... 
No charges for normal UPI-based dig...